SCHEMBL28088912

SCHEMBL28088912

CCCCCNC(C)(C)CO

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.42
EPHX1 P07099 8/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
NAAA Q02083 1/20 0.36
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27705462 0.98 EPHX1 (0.44) ALDH1A1TSHREPHX1NAAALMNA
SCHEMBL28927455 0.98 EPHX1 (0.44) ALDH1A1TSHREPHX1NAAALMNA
SCHEMBL11767372 0.98 EPHX1 (0.44) ALDH1A1TSHREPHX1NAAALMNA
Hydrochloric Acid SCHEMBL5617919 0.96 EPHX1 (0.43) ALDH1A1TSHREPHX1NAAALMNA
Hydrochloric Acid SCHEMBL9511850 0.96 EPHX1 (0.43) ALDH1A1TSHREPHX1NAAALMNA
Water SCHEMBL8979254 0.96 EPHX1 (0.43) ALDH1A1TSHREPHX1NAAALMNA
Hydrochloric Acid SCHEMBL3692664 0.96 EPHX1 (0.43) ALDH1A1TSHREPHX1NAAALMNA
Bromide SCHEMBL27867563 0.96 EPHX1 (0.43) ALDH1A1TSHREPHX1NAAALMNA
SCHEMBL2114006 0.93 TSHR (0.36) ALDH1A1TSHREPHX1SMN1; SMN2LMNA
SCHEMBL12927516 0.90 HTT (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104024258-B Pyrrolopyrazine kinase inhibitors 霍夫曼-拉罗奇有限公司 2017-02-15 CN claimed
CN-106349156-A Pyridine-2-amides capable of being used as CB2 agonist 霍夫曼-拉罗奇有限公司 2017-01-25 CN claimed
CN-103608332-B Pyridine-2-amides useful as CB2 agonists 霍夫曼-拉罗奇有限公司 2016-09-28 CN claimed
CN-109310673-A With selective CB2The method of receptor agonist treatment 艾尼纳制药公司 2019-02-05 CN disclosed